Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Heparin Sepharose® (ab193268)

Price and availability

80 409 ₸

Availability

Order now and get it on Thursday February 25, 2021

You may also be interested in

Product image
Anti-CP110 antibody (ab99338)
Product image
Anti-ErbB2 / HER2 antibody [H2Mab-139] (ab264541)
Product image
Anti-PRPF4 antibody (ab69878)
Product image
Recombinant B. subtilis Penicillin-binding protein 4* (His tag) (ab226290)

Overview

  • Product name

    Heparin Sepharose®
  • Product overview

    High binding capacity (>0.4mg/mL). Minimal leaching of ligand. For column or batch purification of heparin-binding proteins & cation exchange (ab193268).


    Contents:


    Supplied as a 50% slurry in 20 % Ethanol; >2.5 mg heparin per mL Sepharose® beads.


     


    Features:


    Heparin beads have been widely used in affinity purification of various heparin-binding proteins or ligands, such as antithrombin III, lipoprotein, as well as DNA binding proteins (transcription factors, virus coat proteins etc). Abcam’s Heparin Sepharose® is designed for purification of heparin-binding proteins and ligands. It can also be used as a high capacity cation exchange medium. Specific proteins can be separated by using different concentrations of salt or a salt gradient. This Heparin Sepharose® formulation exhibits excellent binding capacity, high flow rate, no significant loss of the heparin ligand and a pH stability range of 2-10.


    These beads are for use in column purification. If used in batch purification, we recommend not exceeding 150 x g when centrifuging.


    Store beads at 4°C.


    The beads may be damaged above 40°C.


    DO NOT FREEZE.


    Wash beads 3 times with 3x bead volume of desired buffer before use.


     


    Applications:


    Purification of heparin-binding proteins, enzymes or other ligands.


     


    Sepharose is a registered trademark of GE Healthcare

  • Notes

    Heparin Sepharose® is prepared by covalently coupling heparin to epoxy-activated 6% cross-linked Sepharose® beads. The coupling was optimized to give a high binding capacity and could be greater than 0.4 mg of heparin-binding protein (such as thrombin) per ml of wet gel.

  • Tested applications

    Suitable for: Purificationmore details

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 ml 10 ml 50 ml
    Heparin Sepharose® 1 x 1ml 1 x 10ml 1 x 50ml
  • Research areas

    • Kits/ Lysates/ Other
    • Kits
    • Molecular Biology Kits
    • Beads
    • Heparin

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450)

  •  
  • Product image

    Anti-UBF1 antibody [EP2741Y] - BSA and Azide free (ab239866)

  •  
  • Product image

    Alexa Fluor® 647 Anti-NuMA antibody [EP3976] (ab204018)

  •  
  • Product image

    Anti-Nidogen 2/NID-2 antibody [EPR8697] - BSA and Azide free (ab248402)

  •  
  • Product image

    Alexa Fluor® 488 Anti-CRISPR-Cas9 antibody [EPR19799] (ab215249)

  •  
  • Product image

    Hyaluronic acid disaccharide ΔDiHA sodium salt (ab273641)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.